CBCC Global Research and StepWise Medical Enter Into Joint Global Collaboration
CBCC Global Research and StepWise Medical, LLC, have entered into a joint agreement that provides a broad framework for cooperation between the two companies.
BAKERSFIELD, Calif. and MENLO PARK, Calif., July 22, 2021 /PRNewswire-PRWeb/ -- CBCC Global Research and StepWise Medical, LLC, have entered into a joint agreement that provides a broad framework for cooperation between the two companies. This relationship is an important step for CBCC to further align its strategy of expanding its existing footprint as well as provide access to next-generation technologies for accelerating clinical research. "CBCC is excited about forming this relationship with StepWise Medical, as it demonstrates our commitment to partnerships that move clinical research forward for our clients. The agreement furthers CBCC's goal of providing a broader base of novel digital services for our clients and sponsors", said Manoj Vyas, CEO for CBCC Global Research.
StepWise Medical will benefit from access to an integrated full-service global clinical operation for its spin-out companies, as well as implementation of its newly created AI-driven, biomarker-based software to detect, diagnose, and predict progression of ophthalmic conditions and diseases, whose immediate applications are clinical decision and clinical study support. "StepWise Medical has grown quickly to become a viable healthcare accelerator in the ophthalmology space by having the right teams and corporate partners to support our portfolio companies. We are excited about this new partnership," said Dr.Vartan Ghazarossian, CEO of StepWise Medical.
About CBCC Global Research
CBCC Global Research is a contract research organization (CRO) focused on pharmaceuticals, medical devices, and technologies in therapeutic areas including oncology, ophthalmology, neuro/psychiatry, dermatology, among others. CBCC provides a wide spectrum of clinical research services including phase I-IV clinical trial services and monitoring, data management, medical and regulatory related consulting and writing, core lab & formulation services, and post-marketing registry trials for companies in the bio-pharmaceutical, medical device, and diagnostics industries globally. CBCC is headquartered in California, with offices in Bakersfield, CA and Ahmedabad, India, with remote personnel and partner offices in Japan, China, and Eastern Europe.
About StepWise Medical
StepWise Medical is a health technology start-up accelerator that was established to evaluate and launch healthcare companies. The focus of the company is the creation of novel diagnostic and therapeutic products for ophthalmology and optometry, addressing important unmet clinical needs for both practitioners and patients. One emphasis of the company is innovative approaches in the diagnosis and treatment of Dry Eye Disease, as the prevalence of this disease continues to increase. To date, the company has spun out six standalone companies: Visant Medical, Amaros, Omera Medical, Arya Medical, Octavia Medical and TearOptix. Amaros has developed an AI-driven, biomarker-based software platform to accelerate the pace of clinical development and transform the future of ophthalmic drug and device development. The software that has been developed may be applicable to many disciplines, such as oncology, dermatology and others.
Contacts:
For CBCC Global Research
Sanjeev Ganatra
SVP, Sales & Marketing
[email protected]
@cbcc_global
For StepWise Medical, LLC.
Vartan Ghazarossian, PhD
Founder and CEO
[email protected]
SOURCE CBCC Global Research
Share this article